WFC Research Update — September 19, 2026

Updated Thesis

Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while earnings grew 16.6% in the same period, helped by a 16% increase in Corporate and Investment Banking revenue that included 24% Markets growth.

The investment grade as of this refresh is B — solid business quality. B-tier business, B-tier valuation with 20.4% upside to $103.68 fair value.

Key Metrics at a Glance

Current price: $86.12

These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.

Our 12–18 Month Outlook

Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Wells Fargo & Company remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.

Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.

[View full WFC research →](/stocks/WFC)